Skip to content

Clinical trials

Phase 2 Basal Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Phase: Phase 2 Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20043
20052
20071
20081
20094
20102
20115
20122
20132
20143
20152
20163
20174
20185
20192
20205
20214
20225
20233
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status9
Recruiting9
Terminated7
Active, not recruiting6
Not yet recruiting3
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Novartis Pharmaceuticals4
Philogen S.p.A.4
Genentech, Inc.3
Hoffmann-La Roche3
Regeneron Pharmaceuticals3
UCSF Benioff Children's Hospital Oakland3
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
PellePharm, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma77
Basal Cell Nevus Syndrome11
Skin Neoplasms11
Carcinoma, Squamous Cell6
Carcinoma, Merkel Cell5
Carcinoma4
Carcinoma, Transitional Cell4
Keratosis, Actinic4
Colorectal Neoplasms3
Melanoma3

Trials

Showing 51 to 75 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.